Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

121. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 41, October 9 to 15, 2017

Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 41, October 9 to 15, 2017 Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 41, October 9 to 15, 2017 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 41, October 9 to 15, 2017 View (...) / Open View Statistics Altmetrics Share Citation World Health Organization. Regional Office for Africa, Health Emergencies Programme . (‎2017)‎. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 41, October 9 to 15, 2017. Influenza Virological Surveillance in the WHO African Region, 3 (‎41)‎, 1 - 3. World Health Organization. Regional Office for Africa. Journal Influenza Virological Surveillance in the WHO African Region, 3 (‎41)‎: 1 - 3 Description 3 p. Collections

2017 WHO

122. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 43, October 23 to 29

Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 43, October 23 to 29 Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 43, October 23 to 29 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 43, October 23 to 29 View/ Open View (...) Statistics Altmetrics Share Citation World Health Organization. Regional Office for Africa, Health Emergencies Programme . (‎2017)‎. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 43, October 23 to 29. Influenza Virological Surveillance in the WHO African Region, 3 (‎43)‎, 1 - 3. World Health Organization. Regional Office for Africa. Journal Influenza Virological Surveillance in the WHO African Region, 3 (‎43)‎: 1 - 3 Description 3 p. Collections Language English

2017 WHO

123. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 42, October 16 to 22

Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 42, October 16 to 22 Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 42, October 16 to 22 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 42, October 16 to 22 View/ Open View (...) Statistics Altmetrics Share Citation World Health Organization. Regional Office for Africa, Health Emergencies Programme . (‎2017)‎. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 42, October 16 to 22. Influenza Virological Surveillance in the WHO African Region, 3 (‎42)‎, 1 - 3. World Health Organization. Regional Office for Africa. Journal Influenza Virological Surveillance in the WHO African Region, 3 (‎42)‎: 1 - 3 Description 3 p. Collections Language English

2017 WHO

124. Operational guidance on sharing Influenza Viruses with Human Pandemic Potential (IVPP) under the Pandemic Influenza Preparedness (PIP) framework

Operational guidance on sharing Influenza Viruses with Human Pandemic Potential (IVPP) under the Pandemic Influenza Preparedness (PIP) framework Operational guidance on sharing Influenza Viruses with Human Pandemic Potential (‎IVPP)‎ under the Pandemic Influenza Preparedness (‎PIP)‎ framework JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Operational guidance on sharing (...) Influenza Viruses with Human Pandemic Potential (‎IVPP)‎ under the Pandemic Influenza Preparedness (‎PIP)‎ framework View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. Operational guidance on sharing Influenza Viruses with Human Pandemic Potential (‎IVPP)‎ under the Pandemic Influenza Preparedness (‎PIP)‎ framework. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Description 19 p. Gov't Doc # WHO/WHE/IHM/GIP/2017.3 Other Language Versions

2017 WHO

125. Influenza Virological Surveillance in the WHO African Region

Influenza Virological Surveillance in the WHO African Region Influenza Virological Surveillance in the WHO African Region JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Influenza Virological Surveillance in the WHO African Region View/ Open View Statistics Altmetrics Share Citation World Health Organization. Regional Office for Africa . (‎2017)‎. Influenza Virological (...) Surveillance in the WHO African Region. Influenza Virological Surveillance, 3 (‎34)‎, 1 - 3. World Health Organization. Regional Office for Africa. Journal Influenza Virological Surveillance, 3 (‎34)‎: 1 - 3 Description 3 p. Collections Language English Metadata Related items Showing items related by title and MeSH subject.  World Health Organization (‎ 2010 )‎  World Health Organization (‎ 2011 )‎  World Health Organization (‎ 2010 )‎ View Item

2017 WHO

126. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 29: July 10 to 16 2017

Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 29: July 10 to 16 2017 Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 29: July 17 to 23, 2017 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 29: July 17 to 23, 2017 View/ Open (...) View Statistics Altmetrics Share Citation World Health Organization. Regional Office for Africa, Health Emergencies Programme . (‎2017)‎. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 29: July 17 to 23, 2017. Influenza Virological Surveillance, 3 (‎29)‎, 1 - 3. World Health Organization. Regional Office for Africa. Journal Influenza Virological Surveillance, 3 (‎29)‎: 1 - 3 Description 3 p. Collections Language English Metadata Related items Showing items

2017 WHO

127. Influenza vaccine response during the start of a pandemic: report of the second WHO informal consultation held in Geneva, Switzerland, 21 - 22 July 2016

Influenza vaccine response during the start of a pandemic: report of the second WHO informal consultation held in Geneva, Switzerland, 21 - 22 July 2016 Influenza vaccine response during the start of a pandemic: report of the second WHO informal consultation held in Geneva, Switzerland, 21 - 22 July 2016 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Influenza vaccine (...) response during the start of a pandemic: report of the second WHO informal consultation held in Geneva, Switzerland, 21 - 22 July 2016 View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. Influenza vaccine response during the start of a pandemic: report of the second WHO informal consultation held in Geneva, Switzerland, 21 - 22 July 2016. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Description 29 p. Gov't Doc # WHO/HSE/PED/GIP/EPI/2017.1

2017 WHO

128. Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses

Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses SCIENTIFIC ADVICE www.ecdc.europa.eu Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza Review of recent systematic reviews and meta-analyses ECDC SCIENTIFIC ADVICE Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza – review of recent systematic reviews and meta-analyses ii (...) (University of Michigan School of Public Health); Jonathan Nguyen-Van-Tam (University of Nottingham) ECDC representatives: Mike Catchpole; Piotr Kramarz; Pasi Penttinen; Angus Nicoll; Kari Johansen; Emmanuel Robesyn; Eeva Broberg; René Snacken; Cornelia Adlhoch; Brenna Deckert; Luciana Muresan Suggested citation: European Centre for Disease Prevention and Control. Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza – review of recent systematic reviews and meta

2017 European Centre for Disease Prevention and Control - Expert Opinion

129. Avian influenza A (H5N1) virus infection

Avian influenza A (H5N1) virus infection Avian influenza A (H5N1) virus infection - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Avian influenza A (H5N1) virus infection Last reviewed: February 2019 Last updated: September 2018 Summary Notifiable condition. Infection control measures, such as standard, droplet, contact, and airborne precautions, are recommended. High case-fatality rate of approximately 53% among (...) . Definition A contagious disease of animals caused by viruses that infect birds and, less commonly, pigs. Avian influenza A viruses are highly species-specific but have infected other mammals and, on rare occasions, have crossed the species barrier to infect humans. Highly pathogenic avian influenza (HPAI) A H5N1 virus originating in poultry and wild birds can be transmitted to humans, with rare cases of infection transmitted between humans. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person

2017 BMJ Best Practice

130. Cohort study: Inactivated influenza vaccination in first trimester does not appear to increase risk of birth defects

Cohort study: Inactivated influenza vaccination in first trimester does not appear to increase risk of birth defects Inactivated influenza vaccination in first trimester does not appear to increase risk of birth defects | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Inactivated influenza vaccination in first trimester does not appear to increase risk of birth defects Article Text Women’s health and midwifery Cohort study Inactivated influenza

2017 Evidence-Based Nursing

131. Isolation and phylogenetic characterization of haemagglutinin and neuraminidase genes of H9N2 low pathogenicity avian influenza virus isolated from commercial layers in India (PubMed)

Isolation and phylogenetic characterization of haemagglutinin and neuraminidase genes of H9N2 low pathogenicity avian influenza virus isolated from commercial layers in India Avian influenza is a highly infectious and dynamically evolving disease of birds causing high morbidity and mortality. It is caused by avian influenza virus (AIV) that belongs to the family Orthomyxoviridae. Two types of AIV have been described based on their pathogenicity viz. highly pathogenic avian influenza virus (...) that causes severe disease with high mortality and low pathogenic avian influenza virus (LPAI) that generally causes asymptomatic infection or a mild disease. The H9N2 subtype is the widely circulated LPAI type in the world. The H9N2 subtype of was first reported from northern India in March 2003. However, systematical surveillance information for the evolution of H9N2 viruses in poultry flocks of Southern India is lacking. The present study reports the isolation and characterization of H9N2 isolates from

Full Text available with Trip Pro

2016 Virusdisease

132. Knowledge of H7N9 avian influenza and intention to adopt preventive behaviours among Chinese poultry farmers: a cross-sectional study. (PubMed)

Knowledge of H7N9 avian influenza and intention to adopt preventive behaviours among Chinese poultry farmers: a cross-sectional study.

2016 Lancet

133. Risk for Congenital Malformation With H1N1 Influenza Vaccine: A Cohort Study With Sibling Analysis. (PubMed)

Risk for Congenital Malformation With H1N1 Influenza Vaccine: A Cohort Study With Sibling Analysis. Earlier studies reporting varying risk estimates for congenital malformation in offspring of mothers undergoing vaccination against H1N1 influenza during pregnancy did not consider the potential role of confounding by familial (genetic and shared environmental) factors.To evaluate an association between maternal H1N1 vaccination during pregnancy and offspring malformation, with familial factors (...) taken into account.Population-based prospective study.Sweden.Liveborn offspring born between 1 October 2009 and 1 October 2011 to mothers receiving monovalent AS03-adjuvanted H1N1 influenza vaccine (Pandemrix [GlaxoSmithKline]) during pregnancy. A total of 40 983 offspring were prenatally exposed to the vaccine, 14 385 were exposed within the first trimester (14 weeks), and 7502 were exposed during the first 8 weeks of pregnancy. Exposed offspring were compared with 197 588 unexposed offspring

2016 Annals of Internal Medicine

134. Influenza infection modulates vesicular trafficking and induces Golgi complex disruption (PubMed)

Influenza infection modulates vesicular trafficking and induces Golgi complex disruption Influenza A virus (IFV) replicates its genome in the nucleus of infected cells and uses the cellular protein transport system for genome trafficking from the nucleus to the plasma membrane. However, many details of the mechanism of this process, and its relationship to subsequent cytoplasmic virus trafficking, have not been elucidated. We examined the effect of nuclear transport inhibitors Leptomycin B (LB (...) the export of virus. Inhibition of vesicular trafficking by BFA, NOC, and ZWEHD also affected influenza infection. Interestingly, IFV infection induced fragmentation of the Golgi complex resulting in diffuse distribution of large and small vesicles throughout the cytoplasm. Live-cell microscopy revealed expansion of Golgi localization signals indicating progressive dispersion of Golgi positive structures, resulting in the disassembly of the Golgi ribbon structure. Other vesicular components (Rab1b, ARF1

Full Text available with Trip Pro

2016 Virusdisease

135. Acute posterior multifocal placoid pigment epitheliopathy and granulomatous uveitis following influenza vaccination (PubMed)

Acute posterior multifocal placoid pigment epitheliopathy and granulomatous uveitis following influenza vaccination To report a case of acute placoid multifocal posterior pigment epitheliopathy (APMPPE) following influenza vaccination. The patient exhibited granulomatous uveitis during the recovery phase.A woman in her thirties developed flu-like symptoms seven days after receiving an influenza vaccination. Approximately 2 weeks later, the patient reported with conjunctival injection, blurred (...) , and macular edema were observed and were treated with topical steroid eye drops. No systemic disorders including sarcoidosis, tuberculosis, and Wegener's granulomatosis were present.As influenza vaccinations are administered worldwide, ophthalmologists should be aware of the ocular side effects following vaccination. Although rare, the possibility of APMPPE occurrence following influenza vaccination should be considered; additionally, the recovery phase of APMPPE may be associated with granulomatous

Full Text available with Trip Pro

2016 American journal of ophthalmology case reports

136. Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults. (PubMed)

Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults. Influenza is an infectious virus affecting both humans and animals. In humans, symptoms present as fever, cough, sore throat, runny nose, headache, muscle and joint pain, and malaise. The epidemiological profile of influenza is influenced by multiple factors, including transmissibility of the virus and the susceptibility of the population. Annually, influenza is estimated to infect (...) 5% to 10% of adults, with higher rates in winter seasons in countries with seasonal variation. Exercise could be an intervention to enhance immune response and limit influenza incidence and its related complications.To assess the efficacy and safety of short and long-term exercise prior to influenza vaccination in enhancing influenza prevention in adults.We searched CENTRAL (2015, Issue 11), which contains the Cochrane Acute Respiratory Infections Group's Specialised Register, MEDLINE (1966 to 3

Full Text available with Trip Pro

2016 Cochrane

137. Seroconversion and immunogenicity evaluation of seasonal influenza vaccine in mice model (PubMed)

Seroconversion and immunogenicity evaluation of seasonal influenza vaccine in mice model Influenza virus is epidemiologically very important due to the antigenic variations occurring in it. In present study isolation and identification of influenza virus was attempted from Kasauli and adjoining areas. 71 clinical samples i.e. throat washings were processed and inoculated into the eggs for virus isolation. The isolated strains of H3N2, H1N1 and Influenza B were identified, purified and passaged (...) in eggs. The harvested virus was inactivated by 0.03 % formalin and three formulations of crude, inactivated, whole virus monovalent vaccine for H3N2, H1N1 and influenza B as well as a trivalent vaccine was prepared. The immunogenicity study of the vaccine was performed in the mouse model by using varying dilutions of four types of vaccines for a period of 40 days. The impact of booster dose was also analyzed in the study. A significant seroconversion was observed in the mice sera verifying

Full Text available with Trip Pro

2016 Virusdisease

138. Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children: A Cluster Randomized Blinded Trial. (PubMed)

Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children: A Cluster Randomized Blinded Trial. Whether vaccinating children with intranasal live attenuated influenza vaccine (LAIV) is more effective than inactivated influenza vaccine (IIV) in providing both direct protection in vaccinated persons and herd protection in unvaccinated persons is uncertain. Hutterite colonies, where members live in close-knit, small rural communities in which influenza virus infection regularly (...) occurs, offer an opportunity to address this question.To determine whether vaccinating children and adolescents with LAIV provides better community protection than IIV.A cluster randomized blinded trial conducted between October 2012 and May 2015 over 3 influenza seasons. (ClinicalTrials.gov: NCT01653015).52 Hutterite colonies in Alberta and Saskatchewan, Canada.1186 Canadian children and adolescents aged 36 months to 15 years who received the study vaccine and 3425 community members who did

2016 Annals of Internal Medicine

139. Differential proteomic analysis of respiratory samples from patients suffering from influenza (PubMed)

Differential proteomic analysis of respiratory samples from patients suffering from influenza The exact molecular pathways involved in the pathogenesis of influenza are yet unclear. In the present study we investigated the upper respiratory proteome in influenza patients. 200 nasal and throat swab samples were collected from patients suffering from acute respiratory illness. These samples were confirmed for influenza pandemic A/H1N1/2009 and influenza type B using qRT-PCR. 10 similar swabs were (...) -signaling, transport, and tumor suppression constituted 10 % each, where as 5 % of proteins each belong to Nicotinic acetylcholine receptor, Protein Synthesis and anti-bacterial proteins. 10 % of the proteins have not been described previously. This is the first report on respiratory proteome profile in Influenza patients. The study emphasizes the role of such profiling studies using multiple platforms for bio-marker discoveries, especially non-invasive diagnostic marker in Influenza and other

Full Text available with Trip Pro

2016 Virusdisease

140. Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus pneumonia—a new therapeutic strategy? (PubMed)

Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus pneumonia—a new therapeutic strategy? Influenza viruses (IVs) circulate seasonally and are a common cause of respiratory infections in pediatric and adult patients. Additionally, recurrent pandemics cause massive morbidity and mortality worldwide. Infection may result in rapid progressive viral pneumonia with fatal outcome. Since accurate treatment strategies are still missing, research refocuses

Full Text available with Trip Pro

2016 Molecular and cellular pediatrics